The Elite Research Network is a collaborative network of independently owned, multi-specialty sites located throughout the United States, which condct clinical studies across a broad range of therapeutic areas in all clinical phases. By locating appropriate studies that match our sites’ capabilities and patient populations, our sites consistently meet or exceed enrollment goals. Sites within the network must meet and maintain certain entrance criteria. Each site has a dedicated research staff consisting of highly trained, board certified investigators, study coordinators, patient recruiters, and support staff. Sites have EDC capabilities, use central IRBs with start-up regulatory document turnaround time within 5 days or less, and are in full compliance with FDA, GCP, ICH, and IRB guidelines. Serving as a central point of contact for the network saves our clients time and resources by streamlining information to our sites in order to make informed decisions about which studies are most appropriate. This allows site identification, feasibility, and study start up to occur at an accelerated pace.
Looking for a particular Elite Research Network employee's phone or email?
The Elite Research Network annual revenue was $11 million in 2026.
Chris Hoyle is the Founder and CEO of Elite Research Network.
2 people are employed at Elite Research Network.
The NAICS codes for Elite Research Network are [3254, 325, 32].
The SIC codes for Elite Research Network are [80, 283, 28].